47 results on '"Santos MD"'
Search Results
2. A Case of Painful Visual Loss - Managing Orbital Compartment Syndrome in the Emergency Department
- Author
-
Pelletier, DO, Jessica, Croft, MD, Alexander, Pajor, MD, Michael, Santos, MD, Matthew, Char, MD, Douglas, Mendelsohn, MD, MPH, Marc, and Romo, MD, Ernesto
- Abstract
Audience: Emergency medicine (EM) residents. This simulation curriculum may also be utilized for senior medical students conducting EM rotations.Background: Ophthalmologic education represents only a small portion of medical school curriculums and continues to decrease over time, leaving physicians poorly equipped to diagnose and manage eye complaints.1 Of emergency physicians (EPs) surveyed, 72.5% felt that they could diagnose orbital compartment syndrome (OCS), yet only 40.3% felt comfortable performing a necessary lateral canthotomy and cantholysis (LCC).2 These survey results demonstrate the urgent need for improved ophthalmology education in EM residency to help us diagnose and manage potentially vision-threatening pathology.Educational Objectives: By the end of this simulation, learners will be able to: 1) demonstrate the major components and a systematic approach to the emergency ophthalmologic examination, 2) develop a differential diagnosis of sight-threatening etiologies that could cause eye pain or vision loss, 3) demonstrate proficiency in performing potentially vision-saving procedures within the scope of EM practice.Educational Methods: Low-fidelity simulation was conducted using a novel model adapted from that used by Phillips et al. during their ophthalmology day in the Department of Emergency Medicine at Vanderbilt University.3 The simulation case was developed by an interdepartmental team of ophthalmologists and EPs at our institution.Research Objectives: To evaluate for statistically significant changes in self-efficacy, knowledge, and performance after an educational intervention. Our primary outcome was defined as a checklist-based performance on a simulated case of orbital compartment syndrome necessitating LCC.Research Methods: We conducted a single-center prospective pre- and post-interventional study evaluating the impact of an educational intervention on EM resident management of a simulated case of OCS. Our two- part study intervention consisted of a lecture on OCS followed by a four and a half hour ophthalmology education day (OED). Residents were evaluated using self-efficacy scales (SES), multiple-choice questions (MCQ), and a performance checklist (developed via a modified Delphi process) at three timepoints: Pre- intervention, immediate post-intervention, and three months post-intervention. Post-graduate year (PGY)-1 through PGY-4 EM residents at an Urban Level 1 Trauma Center participated.Results: Initial recruitment consisted of 18 residents (PGY-1 through PGY-4), and 16 residents (PGY-1 through PGY-3) completed the study. Nine residents participated in the OED and seven residents did not. There were no pre-existing differences in median checklist-based performance, MCQ, or SES scores prior to the intervention. At three months post-OED, the OED attendees scored statistically significantly higher on checklist-based performance than non-attendees (lecture only).Discussion: Ophthalmology education in physician training is limited, and EP comfort with performing vision- saving procedures is poor. We developed a simulation case involving such a vision-saving procedure as well as an ophthalmology curriculum that increased skill retention surrounding management of ophthalmologic emergencies.Topics: Emergency medicine (EM), ophthalmology, orbital compartment syndrome (OCS), retrobulbar hematoma, vision loss, eye pain.
- Published
- 2024
3. Ventricular tachycardia: Focal pulsed field electroporation as a rescue therapy
- Author
-
Rita Reis Santos, MD, Mariana Sousa Paiva, MD, Rita Amador, MD, Daniel Matos, MD, Pedro Carmo, MD, and Pedro Adragão, MD, PhD
- Subjects
Ventricular tachycardia ,Arrhythmia ,Electroanatomic mapping ,Ablation ,Focal pulsed field electroporation ,Diseases of the circulatory (Cardiovascular) system ,RC666-701 - Published
- 2024
- Full Text
- View/download PDF
4. Long gun violence in California versus Texas: How legislation can reduce firearm violence
- Author
-
Jonathan Shipley, BS, Areg Grigorian, MD, Lourdes Swentek, MD, Cristobal Barrios, MD, Catherine Kuza, MD, Jeffrey Santos, MD, and Jeffry Nahmias, MD, MHPE
- Subjects
Surgery ,RD1-811 - Abstract
Introduction: Long guns (LGs) are uniquely implicated in firearm violence and mass shootings. On 1/1/2019 California (CA) raised the minimum age to purchase LGs from 18 to 21. This study aimed to evaluate the incidence of LG violence in CA vs. Texas (TX), a state with rising firearm usage and fewer LG regulations, hypothesizing decreased LG firearm incidents in CA vs increased rates in TX after CA LG legislation. Methods: A retrospective analysis of the Gun Violence Archive (2015–2021) was performed. An additional analysis of all firearm incidents within TX and CA was performed. CA and TX census data were used to calculate incidents of LG violence per 10,000,000 people. The primary outcome was the number of LG-related firearm incidents. Median yearly rates of LG violence per 10,000,000 people were compared for pre (2015–2018) vs post (2019–2021) CA LG legislation (Senate Bill 1100 (SB1100). Results: Median LG incidents decreased in CA post-SB1100 (4.21 vs 1.52, p
- Published
- 2024
- Full Text
- View/download PDF
5. Donor and recipient risk assessment and its influence on clinical outcome in heart transplantation at a reference center in Brazil
- Author
-
Gabriel B. Aulicino, MD, Fabiana G. Marcondes-Braga, MD, PhD, Sandrigo Mangini, MD, PhD, Iascara W. Campos, MD, PhD, Monica S. Avila, MD, PhD, Luis F.B. Seguro, MD, PhD, Ronaldo H.B. Santos, MD, Fabio A. Gaiotto, MD, PhD, and Fernando Bacal, MD, PhD
- Subjects
heart transplantation ,prognosis ,heart failure, systolic ,shock, cardiogenic ,cardiomyopathies ,Surgery ,RD1-811 ,Specialties of internal medicine ,RC581-951 - Abstract
Background: Heart transplantation is the gold standard treatment for end-stage heart failure patients. However, the shortage of donor hearts limits its applicability. This study aims to evaluate the risk factors associated with survival within 1-year after heart transplantation. Methods: A single-center retrospective cohort study evaluated 299 adult patients who underwent transplantation at the Heart Institute (Incor) between January 2013 and December 2019. Univariate and multivariate Cox regression analyses were conducted to identify independent predictors of 1-year survival among well-established prognostic clinical characteristics described in the literature. Patients were followed until death or the last observation on October 12, 2022. A Simple Risk Index was created based on the hazard ratio of each factor. Results: Chagas disease was the most common cause of cardiomyopathy (36%). Most patients were male (65%) with a median age of 50 (39-58) years. Four variables observed during the last clinical assessment in the intensive care unit before surgery were found to be statistically significant: maximum Sequential Organ Failure Assessment (SOFA) score, creatinine clearance in 3 quartile categories, C-reactive protein in 3 categories, and white blood cell count in 3 categories. The model demonstrated good discrimination (C-index = 0.74) and calibration. The group at high risk (>20 points) exhibited significantly higher mortality rates at 1 year (p
- Published
- 2024
- Full Text
- View/download PDF
6. A Qualitative Exploration of Sacred Moments in Radiation Oncology
- Author
-
Kirin Saint, MD, Rachel Ehrlinger, BA, Jaime Gilliland, MA, Michael F. Barton, MD, MPH, Amy J. Xu, MD, PhD, Patricia Mae G. Santos, MD, MS, and Divya Yerramilli, MD, MBE
- Subjects
Medical physics. Medical radiology. Nuclear medicine ,R895-920 ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Purpose: While there are many benefits to radiation oncology services, there can be emotional burdens in the care of patients with advanced cancer. Burnout is a prevalent problem in oncology. Existing literature suggests refocusing attention on providers’ sense of purpose to protect against burnout. “Sacred moments” are moments of deep interconnection between people with accompanying spiritual emotions such as awe, joy, and gratitude. These moments naturally occur in health care settings, offering potential benefits to both patient and provider. Little is known about the prevalence and impact of sacred moments among health care workers in a radiation oncology setting. Methods and Materials: We conducted an exploratory qualitative study of 13 semi-structured interviews among physicians, registered nurses, and advanced practice providers of a radiation oncology consult service at a large National Cancer Institute-designated cancer center between March and May 2023. Interviews were recorded, transcribed, and analyzed to identify key themes. Data were systematically coded and analyzed in NVivo software and organized into a codebook organized by domains and themes. Results: Of the 13 health care workers interviewed, 12 interviewees reported experiencing at least one sacred moment during their clinical careers. None of the interviewees were initially familiar with the term; however, all understood the concept once explained. Interview findings were organized into four domains: (1) common elements, (2) impact, (3) barriers, and (4) provider reactions. Common elements included a moment of deep interconnection between provider and patient, often involving end-of-life patients. The impact of these moments was most commonly described as an increased sense of purpose in their role. Lack of time with patients was the most common barrier. Conclusions: Sacred moments are commonly experienced by health care workers in a radiation oncology consult service. They helped to humanize the patient, buffer against provider burnout, and increase a sense of purpose and job satisfaction.
- Published
- 2024
- Full Text
- View/download PDF
7. Analgesic Use of Virtual Reality for Burn Dressing Changes in Low- and Middle-income Countries: A Feasibility Study
- Author
-
Theodore Brown, BA, Alli Dee, Meghan McCullough, MD, Pedro Santos, MD, and David Kulber, MD
- Subjects
Surgery ,RD1-811 - Abstract
Background:. The paucity of pain management options in resource-limited settings is a significant and systemically unaddressed problem. To improve global health equity, it is important to bridge this gap in care without introducing the peril of opioid dependence. We present a proof-of-concept case series wherein virtual reality (VR) was successfully used to manage discomfort in patients undergoing burn dressing changes in sub-Saharan Africa. Methods:. Nine patients presenting with burn injuries of variable severity underwent routine stabilization and dressing as part of standard-of-care treatment. During dressing changes, a VR intervention consisting of the Dream Flight interactive game displayed on an Oculus Quest 2 headset was offered to patients. Patient mood scores were collected before VR initiation and at the conclusion of the dressing change by a translator using the Youth Feelings Scale. Results:. There were no adverse events associated with use of the VR headset and no patients elected to terminate the VR during their procedure. Patients and physicians subjectively reported satisfaction with the device’s utility in the procedure. Before VR initiation, the 95% confidence interval for patient mood score was 4.89 ± 1.725. After VR initiation, the 95% confidence interval for patient mood score was 8.78 ± 1.40. Conclusions:. Our results of this proof-of-concept case series to suggest both feasibility of use and positive influence on patient discomfort and periprocedural satisfaction. We propose that VR should be explored as an analgesic alternative and/or adjunct to narcotics in resource-limited countries, particularly for high-pain, low-duration procedures.
- Published
- 2024
- Full Text
- View/download PDF
8. List of contributors
- Author
-
Abdullah, Kalil, primary, Al-Asad, Reef K., additional, Batool, Syeda Maheen, additional, Brodsky, Jacob R., additional, Chae, Ricky, additional, Chari, Divya A., additional, Cochrane, Graham, additional, Cohen, Michael S., additional, Connors, Scott, additional, Crowson, Matthew Gordon, additional, Fallon, Keelin, additional, Garzon-Muvdi, Tomas, additional, Gramer, Robert M., additional, Herman, Seth, additional, Holmes, Sara, additional, Jiam, Nicole T., additional, Juliano, MD, Amy F., additional, Jung, David H., additional, Katz, Leanna W., additional, Kempfle, Judith S., additional, Knoll, Renata M., additional, Kozin, Elliott D., additional, Lee, Daniel J., additional, Littlefield, Philip D., additional, MacDonald, Kathryn C., additional, Patel, Krupa R., additional, Plitt, Aaron, additional, Reinshagen, Katherine L., additional, Remenschneider, Aaron K., additional, Ronner, Evette A., additional, Santos, MD, Felipe, additional, Shaye, David A., additional, Song, MD, Yohan, additional, Stapleton, Christopher J., additional, Vranic, Justin E., additional, and Wu, Matthew J., additional
- Published
- 2024
- Full Text
- View/download PDF
9. Facial nerve injury following temporal bone fracture: diagnosis and management
- Author
-
Song, MD, Yohan, primary, Juliano, MD, Amy F., additional, and Santos, MD, Felipe, additional
- Published
- 2024
- Full Text
- View/download PDF
10. Facial tumor in an indigenous child from the Brazilian Amazon
- Author
-
Adryadne da Silva Adolfs, MD, Rosilene Viana de Andrade, MD, Maria Clara da Silva Lima, MD, Henrique Albuquerque, MD, and Luciana Mendes dos Santos, MD, PhD
- Subjects
Amazon ,facial tumor ,immunohistochemistry ,indigenous child ,Dermatology ,RL1-803 - Published
- 2024
- Full Text
- View/download PDF
11. Medial-Sided Repair in Multi-Ligamentous Knee Injury
- Author
-
Rohan R. Patel BS, Joshua S. Green MS, Jay Moran MD, Estevao Santos MD, and Michael J. Medvecky MD
- Subjects
Sports medicine ,RC1200-1245 ,Orthopedic surgery ,RD701-811 - Abstract
Background: Injuries to the medial structures of the knee are common in multi-ligamentous knee injuries (MLKIs), which account for 0.02% of orthopedic injuries each year. The most common medial structure involved is the superficial medial collateral ligament (sMCL) with possible additional injury to the posterior oblique ligament (POL) and deep medial collateral ligament (dMCL). There has been little evidence for the superior management of these structures regarding the use of repair or reconstruction to reproduce overall knee function. Although reconstruction may provide more valgus stability postoperatively, the use of sMCL repair over reconstruction may be superior at reestablishing native anatomic alignment and kinematic relationships of the knee while also preserving proprioception and providing similar valgus stability. Indications: Surgical repair of medial structures is typically indicated for third-degree injuries, bony avulsions, tibial plateau fracture, intra-articular entrapment of the end of the ligament (Stener-type lesions), or anteromedial stability. They are particularly indicated in the elite athlete who presents with excessive valgus laxity due to valgus knee loading, external rotation, or combined force vectors. Technique Description: This surgical technique video demonstrates an open, medial-sided femoral and tibial approach to repair proximal and distal medial knee structures in the setting of MLKIs using case examples of a Stener lesion and a combined sMCL, POL, and medial patellofemoral ligament tears. Results: Repair of sMCL injuries has been reported to show favorable healing, knee stability, and function. Discussion/Conclusion: The use of fixation of the sMCL to its anatomical attachment points offers similar valgus stability and improved functional and patient-reported outcomes when compared with sMCL reconstruction. Patient Consent Disclosure Statement: The author(s) attests that consent has been obtained from any patient(s) appearing in this publication. If the individual may be identifiable, the author(s) has included a statement of release or other written form of approval from the patient(s) with this submission for publication.
- Published
- 2024
- Full Text
- View/download PDF
12. Biomarkers Profile in Provoked Unprovoked Deep Venous Thrombosis
- Author
-
Isabela Rodrigues Tavares MD, Roberto Augusto Caffaro MD, PhD, Maria Fernanda Portugal MD, PhD, Camilla Moreira Ribeiro PhD, Viviane Santana da Silva MD, Emily Krupa MD, Srdjan Nikolovski MD, Karen Falcão de Britto MD, Ana Cláudia Gomes Pereira Petisco MD, Maria Cristina Miranda MD, Sandra Gomes de Souza Santos MD, Marcela da Silva Dourado MD, Paula Veloso Siqueira PhD, Fakiha Siddiqui PhD, Jawed Fareed PhD, and Eduardo Ramacciotti MD, PhD
- Subjects
Diseases of the circulatory (Cardiovascular) system ,RC666-701 - Abstract
Venous thromboembolism (VTE), including deep venous thrombosis (DVT) and pulmonary embolism (PE), represents a substantial healthcare challenge. Provoked and unprovoked DVT cases carry distinct risks and treatment considerations. Recognizing the limitations of this classification, molecular markers may enhance diagnostic precision and guide anticoagulation therapy duration relying on patient history and risk factors. This preliminary, open-label, prospective cohort study was conducted including 15 patients (10 provoked DVT and 5 unprovoked DVT) and a control group of healthy plasmatic subjects. Plasma levels of 9 biomarkers were measured at diagnosis (baseline, day 0, and D0) and after 30 days (day 30-D30). Patient demographics, clinical data, and biomarker concentrations were analyzed. Serum concentrations of D-dimer, von Willebrand factor, C-reactive protein, and Anti-Xa were elevated in DVT groups at D0 compared to controls. No significant differences were observed between the provoked and unprovoked groups on the day of diagnosis and 30 days later. Over 30 days, the provoked group exhibited significant biomarker changes related to temporal assessment. No significant differences were noted in the biomarker profile between provoked and unprovoked DVT groups. This study is indicative of the concept of individualized thrombosis assessment and subsequent treatment for VTE. Larger cohorts are warranted to validate these findings and further define the most appropriate use of the molecular markers.
- Published
- 2024
- Full Text
- View/download PDF
13. Reply
- Author
-
Maria Inês Barradas, MD, Fabiana Duarte, MD, and Inês Coutinho dos Santos, MD
- Subjects
Diseases of the circulatory (Cardiovascular) system ,RC666-701 - Published
- 2024
- Full Text
- View/download PDF
14. Intraoperative Fluorescence Imaging to Identify and Preserve the Fifth Anterior Intercostal Sensory Nerves during Inferior Pedicle Reduction Mammoplasty
- Author
-
Mariano F. Ramírez, MD, Maurice Y. Nahabedian, MD, Horacio Mendoza Santos, MD, Agustin Rancati, MD, Claudio Angrigiani, MD, Fernando Dip, MD, and Alberto O. Rancati, MD
- Subjects
Surgery ,RD1-811 - Abstract
Summary:. Postoperative sensitivity of the nipple–areola complex (NAC) is an important concern for women after reduction mammoplasty. Previous studies have demonstrated that sensory branches of the fifth anterior intercostal nerve are important for innervating the NAC and that using an inferior pedicle technique is associated with improved sensory retention. The significance of this case report is that it demonstrates the importance of the fifth anterior intercostal sensory nerve branches using a prototype fluorescent imaging camera. The benefit of this device is that it can detect intraoperative auto-fluorescence of nerves and facilitate their identification and preservation, potentially facilitating the retention of sensation in the NAC and surrounding skin. The goals of this article are, therefore, to demonstrate the importance of this neurovascular pedicle when the inferior pedicle technique is used for breast reduction; and to provide demonstrative evidence of the nerve’s presence within the fifth anterior intercostal artery perforator pedicle. The case involved a woman with mammary hypertrophy who underwent bilateral reduction mammoplasty using the inferior pedicle technique. Full NAC sensation was demonstrated on postoperative day 3 with complete sensory recovery at 1- and 3-month follow-up confirmed. To our knowledge, this is the first reported instance of the fifth intercostal nerve being visualized during aesthetic breast surgery, demonstrating the importance of this neurovascular bundle for sensory preservation when an inferior pedicle reduction mammaplasty technique is used.
- Published
- 2024
- Full Text
- View/download PDF
15. Left Ventricular Pseudoaneurysm
- Author
-
Isabel Cruz, MD, Adriana Pereira, MD, Rui Pontes dos Santos, MD, Jorge Almeida, MD, and Paulo Pinho, MD
- Subjects
cardiac perforation ,left ventricular pseudoaneurysm ,mitral regurgitation ,Diseases of the circulatory (Cardiovascular) system ,RC666-701 - Abstract
A 55-year-old man submitted to emergency surgery due to cardiac perforation by stabbing. One month later, he presented with chest pain, and a transthoracic echocardiogram revealed moderate-severe mitral regurgitation. After 6 months, a new transthoracic echocardiogram showed a left ventricular pseudoaneurysm, being later submitted to pseudoaneurysm exclusion and mitral valvuloplasty.
- Published
- 2024
- Full Text
- View/download PDF
16. Association of Epigenetic Age and Outcome in Critically Ill Patients
- Author
-
Archana Sharma-Oates, PhD, Jack Sullivan, PhD, Daniel Pestana, MSc, Claudia C. dos Santos, MD, Alexandra Binnie, MD, and Janet M. Lord, PhD
- Subjects
Medical emergencies. Critical care. Intensive care. First aid ,RC86-88.9 - Abstract
OBJECTIVES:. DNA methylation can be used to determine an individual’s biological age, as opposed to chronological age, an indicator of underlying health status. This study aimed to assess epigenetic age in critically ill patients with and without sepsis to determine if higher epigenetic age is associated with admission diagnosis or mortality. DESIGN:. Secondary analysis of whole blood DNA methylation data generated from a nested case–control study of critically ill septic and nonseptic patients. SETTING:. Four tertiary care hospitals in Canada. INTERVENTIONS:. None. PATIENTS:. Critically ill patients with and without sepsis. MEASUREMENTS AND MAIN RESULTS:. Epigenetic age was derived from DNA methylation data using the Hannum and PhenoAge algorithms and deviation from the patient’s chronological age in years was determined. Of the 66 patients with sepsis, 34 were male (51.5%), the mean age was 65.03 years and 25 patients (37.8%) died before discharge. Of the 68 nonseptic patients, 47 were male (69.1%), the mean age was 64.92 years and 25 (36.7%) died before discharge. Epigenetic age calculated using the PhenoAge algorithm showed a significant age acceleration of 4.97 years in septic patients (p = 0.045), but no significant acceleration in nonseptic patients. Epigenetic age calculated using the Hannum algorithm showed no significant acceleration in the septic or nonseptic patients. Similarly, in the combined septic and nonseptic cohorts, nonsurvivors showed an epigenetic age acceleration of 7.62 years (p = 0.004) using the PhenoAge algorithm while survivors showed no significant age acceleration. Survivor status was not associated with age acceleration using the Hannum algorithm. CONCLUSIONS:. In critically ill patients, epigenetic age acceleration, as calculated by the PhenoAge algorithm, was associated with sepsis diagnosis and mortality.
- Published
- 2024
- Full Text
- View/download PDF
17. A Dual Phenotype Presentation Linked to a Single Genetic Variant: The Critical Role of CMR
- Author
-
Kevin Rafael De Paula Morales, MD, Rafaela Vieira Franklin Tapias, MD, Artur Ramos Sarmet dos Santos, MD, Andre Vaz, MD, Gabriela Ribeiro Prata Leite Barros, MD, Diana Rodrigues de Araújo, MD, Renan Antonio Daniel, MD, Raphael Scoppetta, MD, Jose Parga, MD, Roberto Torres, MD, and Carlos Eduardo Rochitte, MD, PhD
- Subjects
Diseases of the circulatory (Cardiovascular) system ,RC666-701 - Published
- 2024
- Full Text
- View/download PDF
18. Pulmonary Artery Sarcoma Assessed by Cardiovascular Magnetic Resonance Imaging
- Author
-
Kevin Rafael De Paula Morales, MD, Carlos Eduardo Rochitte, MD, PhD, Eduardo Kaiser Ururahy Nunes Fonseca, MD, PhD, Andre Vaz, MD, Gabriela Ribeiro Prata Leite Barros, MD, Artur Ramos Sarmet dos Santos, MD, Diana Rodrigues de Araújo, MD, Rafaela Vieira Franklin Tapias, MD, Orival Freitas, MD, and Fabio Jatene, MD
- Subjects
Diseases of the circulatory (Cardiovascular) system ,RC666-701 - Published
- 2024
- Full Text
- View/download PDF
19. Characterization of the Septal Discontinuity in Ex-vivohuman Hearts Using DTI: the Potential Structural Determinism Played by Fiberorientation in Clinical Phenotype of Laminopathy Patients
- Author
-
Pierre Cabanis, Julie Magat, PhD, Girish ramlungun, PhD, nestor Pallares-Lupon, PhD, Fanny Vaillant, PhD, Emma Abell, PhD, Cindy Michel, PhD, Philippe Pasdois, PhD, Pierre Dos-Santos, MD, Marion Constantin, MSc, David Benoist, PhD, Line Pourteau, PhD, Virginie Dubes, PhD, Julien Rogier, MD, Louis Labrousse, MD, Mathieu Pernot, MD, Olivier Busuttil, MD, Michel Haissaguerre, MD, Olivier Bernus, PhD, Bruno Quesson, PhD, Edward Vigmond, PhD, Richard Walton, PhD, Josselin Duchateau, MD, and Valéry Ozenne, PhD
- Subjects
Diseases of the circulatory (Cardiovascular) system ,RC666-701 - Published
- 2024
- Full Text
- View/download PDF
20. Myocardial Scar Characteristics by 3D-LGE Cannot Fully Explain Different Arrhythmic Event Rates in Primary and Secondary Prevention of Sudden Cardiac Death
- Author
-
Pedro Freitas, MD, Ana Rita Bello, MD, Rita Amador, MD, Sara Guerreiro, MD, Joao Abecassis, MD, Daniel Matos, MD, Gustavo Rodrigues, MD, João Carmo, MD, Pedro Galvão Santos, MD, Francisco Moscoso Costa, MD, Maria Salomé Carvalho, MD, Pedro Carmo, MD, Diogo Cavaco, MD, Francisco Morgado, MD, António Miguel Ferreira, MD, and Pedro Adragão, MD, PhD
- Subjects
Diseases of the circulatory (Cardiovascular) system ,RC666-701 - Published
- 2024
- Full Text
- View/download PDF
21. Revision Patellar Tendon Reconstruction Using Hamstring Tendon Autograft
- Author
-
Estevao Santos MD, Wasif Islam MD, Michael Amick MD, Giscard J. Adeclat MD, and Michael J. Medvecky MD
- Subjects
Sports medicine ,RC1200-1245 ,Orthopedic surgery ,RD701-811 - Abstract
Background: Patellar tendon ruptures presenting in a chronic setting are rare events that impose technical surgical challenges due to proximal retraction of the patella, quadriceps muscle atrophy and contracture, and peripatellar adhesions. Various reconstruction techniques have been described using different grafts and fixation methods; however, there is a paucity of reported outcomes and there is no consensus on standard of care. Indications: The patient is a 36-year-old man who presented with a failed patellar tendon reconstruction 14 months after his initial surgery (performed 1 year after the initial injury) with functional weakness and loss of extension. The patient was indicated for a revision patellar tendon reconstruction due to persistent functional limitations. Technique Description: The revision patellar tendon reconstruction was performed with gracilis and semitendinosus tendon autografts harvested from the ipsilateral limb. Hardware was removed from the initial graft tunnels in the tibial tubercle and patella. Patellar height was estimated using fluoroscopic measurement of the contralateral patellar tendon length. The graft is first passed through the patellar tunnel, and the individual limbs of the graft are then both placed through the tibial tubercle tunnel. A sternal wire in a figure-of-eight configuration was used to progressively distalize the patella to match the native patellar height, and the graft was then tensioned and secured together. Results: The patient regained full range of motion at 2-year follow-up and was able to return to work and activities without functional limitations. Recent case series also using ipsilateral hamstring tendon autograft for chronic patellar tendon reconstruction report improved patient outcome scores, normal Insall-Salvati index, improved quadriceps strength, and high levels of patient satisfaction. Discussion/Conclusion: Chronic patellar tendon ruptures are technically challenging to treat, especially in the context of revision of a failed reconstruction. The technique presented in this video may aid orthopaedic surgeons in treating this rare but debilitating injury. Given the lack of high-quality evidence, future studies are needed to explore graft choices, graft fixation techniques, and postoperative protocols. Patient Consent Disclosure Statement: The author(s) attests that consent has been obtained from any patient(s) appearing in this publication. If the individual may be identifiable, the author(s) has included a statement of release or other written form of approval from the patient(s) with this submission for publication.
- Published
- 2024
- Full Text
- View/download PDF
22. Demystifying MAFLD: Fatty Liver Disease Mgmt in Primary Care
- Author
-
Santos, MD, Jasmine M. and Santos, MD, Jasmine M.
- Abstract
Objectives Understand the history & evolution of nomenclature of fatty liver disease Review guidance on MAFLD/MASH management Discuss updates to medical management of MAFLD/MASH Apply knowledge to clinical cases Highlight clinical pearls
- Published
- 2024
23. Enhancing Access to DMPA at JFMA: A QI Initiative
- Author
-
Santos, MD, Jasmine M., Ekezie, MD, Nwando, Franko, MD, Elizabeth, Santos, MD, Jasmine M., Ekezie, MD, Nwando, and Franko, MD, Elizabeth
- Abstract
Agenda Pre-test Background Fact or Fiction Review Guidelines Call to Action Post-test
- Published
- 2024
24. Chapter 11 - Facial nerve injury following temporal bone fracture: diagnosis and management
- Author
-
Song, MD, Yohan, Juliano, MD, Amy F., and Santos, MD, Felipe
- Published
- 2024
- Full Text
- View/download PDF
25. ACIDENTE VASCULAR CEREBRAL SILENCIOSO COM EVOLUÇÃO PARA MOYAMOYA E ANEURISMA EM PACIENTE COM ANEMIA FALCIFORME: RELATO DE CASO
- Author
-
Rocha, TM, Faria, LAB, Frudit, ME, Santos, MD, Vicari, P, Pinheiro, YV, Silva, GS, and Figueiredo, MS
- Published
- 2024
- Full Text
- View/download PDF
26. Assessment of quality of life using the EORTC 30 protocol in patients with soft tissue sarcoma undergoing surgical treatment.
- Author
-
Campos ECR, Dalazoana Filho E, Kono PA, Souza MA, Proença NJ, Santos MD, Salina MVJ, Zanolla PS, Yamaoka LMM, and Miyawaki LN
- Subjects
- Humans, Female, Cross-Sectional Studies, Middle Aged, Male, Adult, Aged, Soft Tissue Neoplasms surgery, Young Adult, Quality of Life, Sarcoma surgery, Sarcoma psychology
- Abstract
Objective: To evaluate the quality of life among patients with Soft Tissue Sarcomas treated at the Evangelic Mackenzie Hospital (HUEM) from 2018 to 2024 and undergoing surgical treatment., Material and Methods: descriptive and cross-sectional analysis of 23 patients with soft tissue neoplasia who underwent surgery and whether they underwent neoadjuvant or adjuvant clinical treatments. Epidemiological, clinical, and pathological data were considered. The EORTC 30 protocol was the instrument used for assessing the patients' quality of life., Results: the main cases were located at extremity in females. Mean age at diagnosis was 47 years. All patients were symptomatic at diagnosis, with pain and a palpable mass being the most prevalent symptom and clinical sign, respectively. The mean time from the onset of symptoms to the date of diagnosis was 9 months. The mean tumor size was 11.68cm. Considering the functional scale, the items physical functioning, role performance and social function were the most affected in the assessment of quality of life. Fatigue and loss of appetite were the most common sign and symptom, respectively. A global measure of quality of life achieved high rates when 50% of patients rated as excellent., Conclusion: Continuous and multidisciplinary oncological care provided to the patient allows for better symptom control, resulting in higher quality of life, which positively impacts the patient's adherence to treatment, their progression, and possibly their survival.
- Published
- 2024
- Full Text
- View/download PDF
27. Lung function in children residents in the largest coal region in Brazil.
- Author
-
Yussef MGA, Santos MD, Penteado JO, Soares MCF, Muccillo-Baisch AL, and Silva Júnior FMRD
- Subjects
- Humans, Brazil epidemiology, Cross-Sectional Studies, Female, Male, Child, Child, Preschool, Respiratory Function Tests, Prevalence, Coal Mining, Infant, Newborn, Infant, Environmental Exposure adverse effects, Air Pollutants analysis, Air Pollutants adverse effects, Risk Factors, Lung physiopathology, Socioeconomic Factors
- Abstract
Coal mining activities release harmful air pollutants, which affect children's health, particularly the lung function. Brazil has a large coal reserve in the southern region, where a coal-fired power plant and two coal mines are located. The study aimed to evaluate the prevalence of altered respiratory function and associated factors in children living in this region. A cross-sectional study was conducted in seven cities. It collected socioeconomic and demographic, prenatal and postnatal care, neonatal outcomes, child health information as well as lung function and air quality. The study included 396 children who lived in a high socio-environmental vulnerability due to low education levels and family income, high percentage of unemployed and families with a high bedroom density. There was a high prevalence of preterm birth, low birth weight and long-term exposure to environmental conditions. The most common respiratory problem in the parents was rhinitis, while in the children was wheezing and pneumonia. The prevalence of respiratory function alteration in the region was 7.78%. Variables associated with altered respiratory function were passive smoking, low birth weight, history of wheezing. The concentration of pollutants was equivalent when comparing stations within the coal mining host town (Candiota) and surrounding towns.
- Published
- 2024
- Full Text
- View/download PDF
28. Replacing the animal fat in Bologna sausages using high internal phase emulsion stabilized with lentil protein isolate (Lens culinaris).
- Author
-
Galvão AMMT, Costa GFD, Santos MD, Pollonio MAR, and Hubinger MD
- Subjects
- Animals, Swine, Humans, Food Handling methods, Plant Proteins, Dietary Fats analysis, Cooking, Male, Female, Adult, Rheology, Soybean Oil chemistry, Taste, Meat Products analysis, Emulsions chemistry, Lens Plant chemistry
- Abstract
High internal phase emulsions (HIPEs) are promising techniques that can replace saturated fat in food without reducing the product's texture, sensory attributes, water-holding capacity, and cooking loss. In the current investigation, 100% pork back fat was replaced by HIPEs formed with lentil protein isolate (LPI) in Bologna sausages. HIPEs were prepared by 25% LPI dispersion (2, 4, 6, and 8%, w/w) and 75% (w/w) soybean oil. HIPEs with higher LPI concentration (4, 6, and 8%, w/w) showed lower droplet size, firmer appearance, and better rheology behavior than 2% LPI. The concentrations LPI (2%, 4%, 6%, and 8%, w/w) led to increased moisture in sausages (FH2, FH4, FH6, and FH8, respectively) compared to the FC. These LPI levels resulted in sausage values for pressed juice similar to the FC and lower energy values than sausages with soybean oil (FO) and pork back fat (FC). Besides, these LPI concentrations (4%, 6%, and 8%, w/w) resulted in a lower oil oxidation level in sausages with HIPEs (FH4, FH6, and FH8, respectively) compared to the control sausage formulation with pork back fat (FC). Bologna sausages elaborated with HIPEs showed emulsion stability values higher than 97%, without significance difference between them. The texture and sensory properties of sausages made with HIPEs were comparable to those made with pork back fat. HIPEs may improve the oxidation stability of the Bologna sausages. These results highlight the effectiveness of HIPEs structured with lentil protein in successfully substituting pork back fat in Bologna sausages with a better nutritional appeal., Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 Elsevier Ltd. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
29. Therapeutic strategies and treatment sequencing in patients with chronic lymphocytic leukemia: An international study of ERIC, the European Research Initiative on CLL.
- Author
-
Chatzikonstantinou T, Scarfò L, Minga E, Karakatsoulis G, Chamou D, Kotaskova J, Iacoboni G, Demosthenous C, Albi E, Alcoceba M, Al-Shemari S, Aurran-Schleinitz T, Bacchiarri F, Chatzileontiadou S, Collado R, Davis Z, de Deus Santos MD, Dimou M, Dmitrieva E, Donaldson D, Dos Santos G, Dreta B, Efstathopoulou M, El-Ashwah S, Enrico A, Frygier A, Galimberti S, Galitzia A, Gimeno E, Guarente V, Guieze R, Harrop S, Hatzimichael E, Herishanu Y, Hernández-Rivas JÁ, Jaksic O, Kalicińska E, Laribi K, Karakus V, Kater AP, Kho B, Kislova M, Konstantinou Ε, Koren-Michowitz M, Kotsianidis I, Kubova Z, Labrador J, Lad D, Laurenti L, Longval T, Lopez-Garcia A, Marquet J, Maslejova S, Mayor-Bastida C, Mihaljevic B, Milosevic I, Miras F, Moia R, Morawska M, Nath UK, Navarro-Bailón A, Olivieri J, Panovska-Stavridis I, Papaioannou M, Pierie C, Puiggros A, Reda G, Rigolin GM, Ruchlemer R, Schipani M, Schiwitza A, Shen Y, Shokralla T, Simkovic M, Smirnova S, Soliman DSA, Stilgenbauer S, Tadmor T, Tomic K, Tse E, Vassilakopoulos T, Visentin A, Vitale C, Vrachiolias G, Vukovic V, Walewska R, Xu Z, Yagci M, Yañez L, Yassin M, Zuchnicka J, Oscier D, Gozzetti A, Panagiotidis P, Bosch F, Sportoletti P, Espinet B, Pangalis GA, Popov VM, Mulligan S, Angelopoulou M, Demirkan F, Papajík T, Biderman B, Murru R, Coscia M, Tam C, Cuneo A, Gaidano G, Claus R, Stavroyianni N, Trentin L, Antic D, Smolej L, Kalashnikova OB, Catherwood M, Spacek M, Pospisilova S, Doubek M, Nikitin E, Chatzidimitriou A, Ghia P, and Stamatopoulos K
- Abstract
Competing Interests: Thomas Chatzikonstantinou received honoraria from AbbVie. Lydia Scarfò received honoraria from AbbVie, AstraZeneca, BeiGene, Lilly, Janssen, Octapharma. Gloria Iacoboni received honoraria and travel support from Novartis, Kite/Gilead, Bristol‐Myers Squibb, Abbvie, Autolus, Miltenyi, and AstraZeneca. Rosa Collado received support for attending meetings from Janssen‐Cilag and S.A. Sara Galimberti received honoraria support for attending meetings from AbbVie, AstraZeneca, Jazz, Novartis, and Incyte, honoraria from Roche, Celgene, Pfizer, and Janssen, and support for attending meetings from Jazz, AstraZeneca, and Roche. Romain Guieze received honoraria, consulting fees, and support for attending meetings from AbbVie, Beigene, Roche, Janssen, and AstraZeneca. Eleftheria Hatzimichael received honoraria from AbbVie, Janssen‐Cilag, AstraZeneca, and Roche. Yair Herishanu received honoraria from Janssen, AbbVie, Roche, AstraZeneca, Medion, and Lilly. José‐Ángel Hernández‐Rivas received honoraria as a consultant from Janssen, AbbVie, AstraZeneca, Lilly, and BeiGene and support for attending meetings from Janssen, AbbVie, AstraZeneca, and BeiGene. Ozren Jaksic received honoraria from Johnson and Johnson, AstraZeneca, and Lilly, honoraria from Johnson and Johnson, AbbVie, AstraZeneca, and Lilly, and support for attending meetings from Johnson and Johnson, and AbbVie. Kamel Laribi received consulting fees from AbbVie, AstraZeneca, Janssen, Beigene, Takeda, and Novartis. Maya Koren‐Michowitz received honoraria from Novartis, Pfizer, and Gad Medical LTD. and support for attending meetings from Novartis. Arnon P. Kater received advisory board fees and research money from Janssen, AbbVie, BMS, AstraZeneca, and Roche/Genentech, and support for attending meetings from Janssen and AbbVie. Ioannis Kotsianidis received honoraria and consulting fees from AbbVie and Janssen. Ivana Milosevic received honoraria from AbbVie, Roche, Sandoz, AstraZeneca, and Janssen, and support for attending meetings from AbbVie, Roche, and Takeda. Almudena Navarro‐Bailón received honoraria, advisory board fees, and support for attending meetings from AbbVie, AstraZeneca, Takeda, Janssen, and Beigene. Jacopo Olivieri received honoraria from AbbVie, AstraZeneca, and Janssen. Gianluigi Reda received consulting fees from AbbVie, AstraZeneca, Janssen, and Beigene, and is currently employed by AstraZeneca. Gian M. Rigolin received honoraria for participation in speaker's bureau from AbbVie, Astra Zeneca, Beigene, and Janssen, and support for attending meetings from Janssen. Mattia Schipani received honoraria and support for attending meetings from AstraZeneca, AbbVie, and Janssen‐Cilag and owns shares of stock in AbbVie, AstraZeneca, Merck, Eli Lilly, Sanofi, Johnson and Johnson, Pfizer, Gilead, and GSK. Tereza Shokralla and Stephan Stilgenbauer reports research funding from, consultancy or advisory role for, honoraria from, speakers' bureau participation for, and travel support from AbbVie, Amgen, AstraZeneca, BeiGene, Bristol Myers Squibb, Celgene, Gilead, GlaxoSmithKline, Hoffmann‐La Roche, Incyte, Infinity, Janssen, Novartis, and Sunesis. Eric Tse received support for attending meetings from Takeda. Theodoros Vassilakopoulos received honoraria from Takeda, Roche, Genesis Pharma, Merck, Novartis, Gilead, Sandoz, AstraZeneca, Integris, and Servier, and support for attending meetings from Takeda, Roche, Genesis Pharma, Merck, Pfizer, and Winmedica. Candida Vitale received honoraria from AbbVie, consulting fees from AstraZeneca, and support for attending meetings from AstraZeneca, Takeda, and Janssen. Renata Walewska received honoraria from AbbVie, AstraZeneca, and Beigene, support for attending meetings from Janssen, AbbVie, and AstraZeneca, and advisory board fees from AbbVie, AstraZeneca, Janssen, Beigene, and SecuraBio. Lucrecia Yañez received honoraria from AbbVie, AstraZeneca, Novartis, Gilead, Janssen, Jazz, MSD, and Pfizer, support for attending meetings from AbbVie, AstraZeneca, Gilead, Janssen, and Pfizer, and advisory board fees from AbbVie, AstraZeneca, Jazz, Janssen, Beigene, and Celgene. Francesc Bosch received consulting fees, honoraria, and payment for expert testimony from AbbVie, Genentech, Novartis, Takeda, Janssen, Roche, Mundipharma, Celgene/BMS, AstraZeneca, Lilly, Beigene, Gilead and TG Therapeutics, Advantage Allogene, Lava Therapeutics, and Enterome. Stephen Mulligan received advisory board fees from AbbVie, AstraZeneca, Janssen, Roche, and BeiGene. Maria Angelopoulou received consulting fees from AbbVie, Takeda, Janssen, Roche, Genesis, Gilead, and Amgen and honoraria from AbbVie, Takeda, Roche, Genesis, Gilead, and Novartis. Fatih Demirkan received support for attending meetings from Janssen and AbbVie. Tomas Papajík received honoraria and advisory board fees from AbbVie, Janssen‐Cilag, and AstraZeneca, and support for attending meetings from AstraZeneca. Marta Coscia received honoraria, advisory board fees, and support for attending meetings from AbbVie, AstraZeneca, and Janssen. Constantine Tam received honoraria from AbbVie, Beigene, Janssen, and LOXO. Antonio Cuneo received honoraria, advisory board fees, and support for attending meetings from AbbVie, AstraZeneca, Beigene, Janssen, and Lilly. Gianluca Gaidano received honoraria from Abbvie, AstraZeneca, BeiGene, Hikma, Incyte, Janssen, and Lilly. Niki Stavroyianni received honoraria from Janssen, AbbVie, AstraZeneca, and Lilly, and support for attending meetings from Janssen and AstraZeneca. Lukas Smolej received consulting fees, honoraria, and support for attending meetings from AbbVie, AstraZeneca, and Janssen and advisory board fees from AbbVie and AstraZeneca. Martin Spacek received honoraria and consulting and advisory board fees, and support for attending meetings from AbbVie, AstraZeneca, and Janssen. Michael Doubek received research support and honoraria from AbbVie, AstraZeneca, and Janssen. Eugene Nikitin received honoraria from AbbVie. Kostas Stamatopoulos received research support from AbbVie, AstraZeneca, Janssen, Novartis, and Roche; honoraria from AbbVie, AstraZeneca, Bristol Myers Squibb, Lilly, and Janssen. Paolo Ghia received research support from AbbVie, AstraZeneca, BMS, Janssen and honoraria from AbbVie, AstraZeneca, BeiGene, BMS, Galapagos, Genmab, Janssen, Loxo Oncology @Lilly, MSD, Roche, and is an Editor of HemaSphere. Georgios Karakatsoulis, Eva Minga, Dimitra Chamou, Jana Kotaskova, Christos Demosthenous, Elisa Albi, Miguel Alcoceba, Salem Al‐Shemari, Thérèse Aurran‐Schleinitz, Francesca Bacchiarri, Sofia Chatzileontiadou, Zadie Davis, Marcos Daniel de Deus Santos, Maria Dimou, Elena Dmitrieva, David Donaldson, Gimena Dos Santos, Barbara Dreta, Maria Efstathopoulou, Shaimaa El‐Ashwah, Alicia Enrico, Andrzej Frygier, Andrea Galitzia, Eva Gimeno, Valerio Guarente, Sean Harrop, Elżbieta Kalicińska, Volkan Karakus, Bonnie Kho, Maria Kislova, Εliana Konstantinou, Zuzana Kubova, Jorge Labrador, Deepesh Lad, Luca Laurenti, Thomas Longval, Alberto Lopez‐Garcia, Juan Marquet, Stanislava Maslejova, Carlota Mayor‐Bastida, Biljana Mihaljevic, Fatima Miras, Riccardo Moia, Marta Morawska, Uttam K. Nath, Irina Panovska‐Stavridis, Maria Papaioannou, Cheyenne Pierie, Anna Puiggros, Rosa Ruchlemer, Annett Schiwitza, Yandong Shen, Tereza Shokralla, Martin Simkovic, Svetlana Smirnova, Dina S. A. Soliman, Tamar Tadmor, Kristina Tomic, Andrea Visentin, George Vrachiolias, Vojin Vukovic, Zhenshu Xu, Munci Yagci, Mohamed Yassin, Jana Zuchnicka, David Oscier, Alessandro Gozzetti, Panagiotis Panagiotidis, Blanca Espinet, Paolo Sportoletti, Gerassimos A. Pangalis, Viola M. Popov, Bella Biderman, Roberta Murru, Rainer Claus, Livio Trentin, Darko Antic, Olga B. Kalashnikova, Mark Catherwood, Sarka Pospisilova, and Anastasia Chatzidimitriou have no conflict of interest to disclose.
- Published
- 2024
- Full Text
- View/download PDF
30. SMART DIABETES HOSPITAL: CLINICAL IMPACT IN COMPLEX SURGICAL UNITS OF A TERTIARY HOSPITAL.
- Author
-
Simó-Servat O, Amigó J, Ortiz-Zúñiga Á, Sánchez M, Cuadra F, Santos MD, Rojano A, Abadías MJ, Roman A, Hernández C, and Simó R
- Abstract
Aim: To evaluate the impact of a proactive action of a specialized diabetes team (SDT) on different health outcomes in patients hospitalized in high complexity surgery units, including solid organ transplant surgical units, of a tertiary hospital., Methods: Nested case control study matched (1:1) by age and gender. The control group consisted of patients (n = 120) who were under the standard of care diabetes management admitted three months' prior the cases. The cases were admitted in the same surgical units (n = 120) and were treated in the setting of the so called "Smart Diabetes Hospital" (SDH) consisting in a SDT that prioritized their actions through a digital map showing blood glucose levels obtained during the previous 24 h., Results: SDH implementation resulted in a significant reduction in both blood glucose levels (mean 162.1 ± SD 44.4 vs. mean 145.5 ± SD 48.0; p = 0.008) and hypoglycaemic episodes (19.7% vs. 8.4%: p = 0.002). Furthermore, a reduction of 3 days in the length of stay (LOS) was observed (15.6 ± 10.3 vs. 12.4 ± 6.0), which represents a significant cost-saving. Moreover, more new cases of diabetes were detected during the SDT period (2.5% vs. 6.7%, p = 0.04)., Conclusion: SDH is effective in diabetes management and reduce LOS in complex surgical units., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
31. Bridging the generational gap between nurses and nurse managers: a qualitative study from Qatar.
- Author
-
Abujaber AA, Nashwan AJ, Santos MD, Al-Lobaney NF, Mathew RG, Alikutty JP, Kunjavara J, and Alomari AM
- Abstract
Background: The nursing workforce comprises multiple generations, each with unique values, beliefs, and expectations that can influence communication, work ethic, and professional relationships. In Qatar, the generational gap between nurses and nurse managers poses challenges to effective communication and teamwork, impacting job satisfaction and patient outcomes., Aim: This study investigates the generational gap between nurses and nurse managers in Qatar, aiming to identify strategies to enhance collaboration and create a positive work environment., Methods: A qualitative research design was used, involving semi-structured interviews with 20 participants, including frontline nurses and senior nurse managers. Participants were purposively sampled to represent different generations. Data were collected through face-to-face and virtual interviews, then transcribed and thematically analyzed., Findings: Four key themes emerged: Optimizing the Work Environment: Older generations preferred transformational and situational leadership, while younger nurses valued respect, teamwork, accountability, and professionalism. Strengthening Work Atmosphere through Communication and values: Older nurses favored face-to-face communication, while younger nurses preferred digital tools. Cultivating Respect and Empathy: Younger nurses emphasized fairness in assignments and promotions, while older nurses focused on empathy and understanding. Dynamic Enhancement of Healthcare Systems: Younger nurses were more adaptable to technology and professional development, while older nurses prioritized clinical care and patient outcomes., Conclusion: The study reveals significant generational differences in leadership preferences, communication styles, and adaptability to technology. Addressing these gaps through effective leadership, ongoing education, and open communication can improve job satisfaction and patient care., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
32. Effect of vitamin D 3 on antiphospholipid antibodies in hospitalized patients with moderate to severe COVID-19.
- Author
-
Sales LP, Souza LVB, Fernandes AL, Murai IH, Santos MD, Vendramini MBG, Oliveira RM, Figueiredo CP, Caparbo VF, Gualano B, and Pereira RMR
- Subjects
- Humans, Male, Female, Middle Aged, Double-Blind Method, Aged, Adult, Severity of Illness Index, Hospitalization statistics & numerical data, SARS-CoV-2 immunology, COVID-19 Drug Treatment, Vitamins therapeutic use, Vitamins administration & dosage, Antibodies, Anticardiolipin blood, Brazil, Immunoglobulin G blood, beta 2-Glycoprotein I immunology, Treatment Outcome, Cholecalciferol therapeutic use, Cholecalciferol administration & dosage, COVID-19 immunology, Antibodies, Antiphospholipid blood
- Abstract
Objective: To investigate the effect of a single oral dose of 200,000 IU of vitamin D
3 on antiphospholipid antibodies in hospitalized patients with moderate to severe COVID-19., Methods: This is a post-hoc, exploratory analysis from a double-blind, placebo-controlled, randomized clinical trial performed in two centers in Sao Paulo, Brazil. Hospitalized patients with COVID-19 were randomly assigned to receive either vitamin D3 (n = 97) or placebo (n = 97). In this post-hoc analysis, the endpoints were titers and frequency of anti-β2-Glycoprotein-I (aβ2-GP) and Anticardiolipin (aCL) antibodies [Immunoglobulin G, M and A (IgG, IgM and IgA)]., Results: Overall mean (SD) age was 55.3 (13.9) years, Body Mass Index (BMI) was 32.2 (7.1 kg/m2 ), and 106 participants (54.6 %) were male. There was a significant group by time interaction (p = 0.046) for frequency of aCL IgG, with increased values from baseline to discharge in the placebo group [n (%), from 13 (13.4) to 25 (25.8)] compared to the vitamin D3 [from 25 (25.8) to 29 (29.9)]. However, the frequency of aCL IgG did not change between the groups on discharge. No significant differences between vitamin D3 and placebo groups were found for any other autoantibodies., Conclusion: These findings do not support the use of a single oral dose of 200,000 IU of vitamin D3 to modulate autoantibodies in hospitalized patients with moderate to severe COVID-19., Competing Interests: Declaration of competing interest The authors declare no conflicts of interest., (Copyright © 2024. Published by Elsevier España, S.L.U.)- Published
- 2024
- Full Text
- View/download PDF
33. Identifying priority sites for whale shark ship collision management globally.
- Author
-
Womersley FC, Rohner CA, Abrantes K, Afonso P, Arunrugstichai S, Bach SS, Bar S, Barash A, Barnes P, Barnett A, Boldrocchi G, Buffat N, Canon T, Perez CC, Chuangcharoendee M, Cochran JEM, de la Parra R, Diamant S, Driggers W, Dudgeon CL, Erdmann MV, Fitzpatrick R, Flam A, Fontes J, Francis G, Galvan BE, Graham RT, Green SM, Green JR, Grosmark Y, Guzman HM, Hardenstine RS, Harvey M, Harvey-Carroll J, Hasan AW, Hearn AR, Hendon JM, Putra MIH, Himawan MR, Hoffmayer E, Holmberg J, Hsu HH, Jaidah MY, Jansen A, Judd C, Kuguru B, Lester E, Macena BCL, Magson K, Maguiño R, Manjaji-Matsumoto M, Marcoux SD, Marcoux T, McKinney J, Meekan M, Mendoza A, Moazzam M, Monacella E, Norman B, Perry C, Pierce S, Prebble C, Macías DR, Raudino H, Reynolds S, Robinson D, Rowat D, Santos MD, Schmidt J, Scott C, See ST, Sianipar A, Speed CW, Syakurachman I, Tyne JA, Waples K, Winn C, Yuneni RR, Zareer I, and Araujo G
- Subjects
- Animals, Endangered Species, Environmental Monitoring, Sharks physiology, Ships, Conservation of Natural Resources
- Abstract
The expansion of the world's merchant fleet poses a great threat to the ocean's biodiversity. Collisions between ships and marine megafauna can have population-level consequences for vulnerable species. The Endangered whale shark (Rhincodon typus) shares a circumglobal distribution with this expanding fleet and tracking of movement pathways has shown that large vessel collisions pose a major threat to the species. However, it is not yet known whether they are also at risk within aggregation sites, where up to 400 individuals can gather to feed on seasonal bursts of planktonic productivity. These "constellation" sites are of significant ecological, socio-economic and cultural value. Here, through expert elicitation, we gathered information from most known constellation sites for this species across the world (>50 constellations and >13,000 individual whale sharks). We defined the spatial boundaries of these sites and their overlap with shipping traffic. Sites were then ranked based on relative levels of potential collision danger posed to whale sharks in the area. Our results showed that researchers and resource managers may underestimate the threat posed by large ship collisions due to a lack of direct evidence, such as injuries or witness accounts, which are available for other, sub-lethal threat categories. We found that constellations in the Arabian Sea and adjacent waters, the Gulf of Mexico, the Gulf of California, and Southeast and East Asia, had the greatest level of collision threat. We also identified 39 sites where peaks in shipping activity coincided with peak seasonal occurrences of whale sharks, sometimes across several months. Simulated collision mitigation options estimated potentially minimal impact to industry, as most whale shark core habitat areas were small. Given the threat posed by vessel collisions, a coordinated, multi-national approach to mitigation is needed within priority whale shark habitats to ensure collision protection for the species., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 The Authors. Published by Elsevier B.V. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
34. Cut-Offs for Disease Activity States in Axial Spondyloarthritis With Ankylosing Spondylitis Disease Activity Score (ASDAS) Based on C-Reactive Protein and ASDAS Based on Erythrocyte Sedimentation Rate: Are They Interchangeable?
- Author
-
Georgiadis S, Ørnbjerg LM, Michelsen B, Kvien TK, Di Giuseppe D, Wallman JK, Závada J, Provan SA, Kristianslund EK, Rodrigues AM, Santos MJ, Rotar Ž, Pirkmajer KP, Nordström D, Macfarlane GJ, Jones GT, van der Horst-Bruinsma I, Hellamand P, Østergaard M, and Hetland ML
- Subjects
- Humans, Male, Female, Adult, Middle Aged, Registries, C-Reactive Protein analysis, Blood Sedimentation, Spondylitis, Ankylosing blood, Spondylitis, Ankylosing diagnosis, Severity of Illness Index, Axial Spondyloarthritis blood, Axial Spondyloarthritis diagnosis
- Abstract
Objective: Ankylosing Spondylitis Disease Activity Score based on C-reactive protein (ASDAS-CRP) is recommended over ASDAS based on erythrocyte sedimentation rate (ASDAS-ESR) to assess disease activity in axial spondyloarthritis (axSpA). Although ASDAS-CRP and ASDAS-ESR are not interchangeable, the same disease activity cut-offs are used for both. We aimed to estimate optimal ASDAS-ESR values corresponding to the established ASDAS-CRP cut-offs (1.3, 2.1, and 3.5) and investigate the potential improvement of level of agreement between ASDAS-ESR and ASDAS-CRP disease activity states when applying these estimated cut-offs., Methods: We used data from patients with axSpA from 9 European registries initiating a tumor necrosis factor inhibitor. ASDAS-ESR cut-offs were estimated using the Youden index. The level of agreement between ASDAS-ESR and ASDAS-CRP disease activity states was compared against each other., Results: In 3664 patients, mean ASDAS-CRP was higher than ASDAS-ESR at both baseline (3.6 and 3.4, respectively) and aggregated follow-up at 6, 12, or 24 months (1.9 and 1.8, respectively). The estimated ASDAS-ESR values corresponding to the established ASDAS-CRP cut-offs were 1.4, 1.9, and 3.3. By applying these cut-offs, the proportion of discordance between disease activity states according to ASDAS-ESR and ASDAS-CRP decreased from 22.93% to 19.81% in baseline data but increased from 27.17% to 28.94% in follow-up data., Conclusion: We estimated the optimal ASDAS-ESR values corresponding to the established ASDAS-CRP cut-off values. However, applying the estimated cut-offs did not increase the level of agreement between ASDAS-ESR and ASDAS-CRP disease activity states to a relevant degree. Our findings did not provide evidence to reject the established cut-off values for ASDAS-ESR., (Copyright © 2024 by the Journal of Rheumatology.)
- Published
- 2024
- Full Text
- View/download PDF
35. Management of Short Bowel Syndrome With Chronic Intestinal Failure: A Single-Center Experience in Portugal.
- Author
-
Santos MD, Magalhães V, Loureiro L, Pina P, Castro A, Aguiar P, and Rocha A
- Abstract
Introduction: Short bowel syndrome with chronic intestinal failure (SBS/CIF) is the inability to maintain protein-energy, fluid, electrolyte, or micronutrient balance due to a short bowel. Although SBS/CIF is rare, its clinical management is complex, challenging, expensive, and time-consuming., Aim: This study aimed to analyze a single center's experience with SBS/CIF in adult patients treated with home parenteral nutrition (HPN)., Materials and Methods: A retrospective single-center analysis of all 13 consecutive adult patients with SBS/CIF was included in an HPN program between January 1994 and August 2023., Results: Between 1992 and 2023, 13 patients were included in an HPN program. The primary underlying pathology was acute mesenteric ischemia. The median age of starting HPN was 44 years. Most were subjected to several surgeries of extensive intestinal resection with posterior intestinal reconstruction. Five of the 13 patients died while on HPN with a median duration of 42 months. The causes of death related to HPN were catheter sepsis, endocarditis with cardiac failure, or hepatic failure. One patient died due to underlying pathology: pelvic abscesses and bleeding related to radiotherapy. Eight patients remain alive, with a median time of HPN of 173 months. During the HPN support, the most frequent complications were venous catheter infection and venous territory thrombosis. None of the eight patients alive have hepatic failure. Two patients recently started teduglutide with good tolerance and need a reduction in HPN support. All eight patients have a satisfactory quality of life (parenteral support needs range between five and two nutrition bags per week). Conclusion: Home parenteral nutrition remains the gold standard of SBS/CIF treatment, although teduglutide may reduce HPN needs and complications and provide a better quality of life. Despite the small number of patients, the results shown in this study are not inferior to those in large-volume centers. The existence of the commitment and interest of professionals involved in SBS/CIF at Centro Hospitalar Universitário de Santo António, Portugal, was a fundamental key to achieving those results. A multidisciplinary healthcare group for HPN support can be essential to ensuring these patients' survival and quality of life., Competing Interests: Human subjects: Consent was obtained or waived by all participants in this study. National Committee for Data Protection and Ethics Committee of Unidade Local de Saúde de Santo António (ULSSA) issued approval (Ref. 2107.211 (181-DEFI/173-CES)). This study was conducted according to the gold standard of ethical recommendations, namely, the last update of the Helsinki Declaration and International Guidelines for Ethical Review of Epidemiological Studies. Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work., (Copyright © 2024, Santos et al.)
- Published
- 2024
- Full Text
- View/download PDF
36. ACE gene polymorphisms (rs4340) II and DI are more responsive to the ergogenic effect of caffeine than DD on aerobic power, heart rate, and perceived exertion in a homogeneous Brazilian group of adolescent athletes.
- Author
-
Spineli H, Santos MD, Almeida D, Gitaí D, Silva-Cavalcante M, Balikian P, Ataide-Silva T, Marinho A, Sousa F, and Araujo G
- Subjects
- Humans, Adolescent, Male, Athletic Performance physiology, Physical Endurance drug effects, Physical Endurance genetics, Polymorphism, Genetic genetics, Brazil, Oxygen Consumption genetics, Oxygen Consumption drug effects, Performance-Enhancing Substances administration & dosage, Heart Rate drug effects, Caffeine administration & dosage, Genotype, Athletes, Physical Exertion physiology, Peptidyl-Dipeptidase A genetics
- Abstract
The purpose of this study was to verify the association between angiotensin-converting enzyme (ACE) genotypes DD, DI, and II and caffeine (CAF) ingestion on endurance performance, heart rate, ratio of perceived exertion (RPE), and habitual caffeine intake (HCI) of adolescent athletes. Seventy-four male adolescent athletes (age: DD=16±1.7; DI=16±2.0; II=15±1.7 years) ingested CAF (6 mg/kg) or placebo (PLA) one hour before performing the Yo-Yo Intermittent Recovery level 1 (Yo-Yo IR1) test. No difference was found among groups for HCI. However, CAF increased the maximal distance covered and VO2max in DI and II genotype carriers compared to PLA (DD: Δ=31 m and 0.3 mL·kg-1·min-1; DI: Δ=286 m and 1.1 mL·kg-1·min-1; II: Δ=160 m and 1.4 mL·kg-1·min-1). Heart rate of DI and II genotype carriers increased with CAF compared to PLA, while RPE was higher in the II and lower in the DD genotypes. The correlations between HCI and maximal distance covered or VO2max were significant in the II genotype carriers with CAF. CAF increased endurance capacity, heart rate, and RPE in adolescent athletes with allele I, while endurance performance and aerobic power had a positive correlation to HCI in the II genotype group. These findings suggested that DD genotype were less responsive to CAF and that genetic variations should be taken into account when using CAF supplementation to enhance exercise performance.
- Published
- 2024
- Full Text
- View/download PDF
37. In silico characterization and homology modeling of Nile tilapia ( Oreochromis niloticus ) Hsp70cBi and Hsp70cBc proteins.
- Author
-
Dayrit GB, Burigsay NPF, Vera Cruz EM, and Santos MD
- Abstract
The molecular chaperone heat shock proteins 70 (Hsp70) play a pivotal role in preserving cellular integrity and managing stress. This study extensively examined two Hsp70 proteins, On -Hsp70cBi, inducible, and On -Hsp70cBc, constitutively expressed, in Nile tilapia ( Oreochromis niloticus ) utilizing in silico analysis, homology modeling, and functional annotation. Employing the SWISS-MODEL program for homology modeling, the proposed models underwent thorough reliability assessment via ProSA, Verify 3D, PROVE, ERRAT, and Ramachandran plot analyses. Key features of On-Hsp70cBi and On-Hsp70cBc included amino acid lengths (640 and 645) and molecular weights (70,233.48 and 70,773.17 Da). Moreover, theoretical isoelectric points (pI = 5.63 and 5.28), indicated their acidic nature. Counts of negatively and positively charged residues (95 and 86; 95 and 81) revealed neutrality, while instability index (II) values of 35.27 ( On -Hsp70cBi) and 38.85 ( On -Hsp70cBc) suggested stability. Aliphatic index (AI) values were notably high for both proteins (84.58 and 82.85), indicating stability across a broad temperature range. Domain architecture analysis showed both proteins to contain an MreB/Mbl domain. Protein-protein interaction analysis identified the co-chaperone Stip1 as a primary functional partner. Comparative modeling yielded highly reliable 3D models, showcasing structural similarity to known proteins and predicted binding sites. Additionally, both proteins are primarily localized in the cytoplasm. Functional analysis predicted an AMP-PNP binding site for On -Hsp70cBi and an ATP binding site for On -Hsp70cBc. These findings deepened our understanding of Hsp70cBc and Hsp70cBi in Nile tilapia, underscoring their significance in fish physiology and warranting further investigation, thus advancing our knowledge of these proteins' roles in cellular processes and stress responses, potentially impacting fish health and resilience., Competing Interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (© 2024 The Authors.)
- Published
- 2024
- Full Text
- View/download PDF
38. B7-H3-Targeting Chimeric Antigen Receptors Epstein-Barr Virus-specific T Cells Provides a Tumor Agnostic Off-The-Shelf Therapy Against B7-H3-positive Solid Tumors.
- Author
-
Yeo SP, Kua L, Tan JW, Lim JK, Wong FH, Santos MD, Poh CM, Goh AX, Koh XY, Zhou X, Rajarethinam R, Chen Q, Her Z, Horak ID, Low L, and Tan KW
- Subjects
- Animals, Humans, Mice, Cell Line, Tumor, Neoplasms therapy, Neoplasms immunology, Female, Single-Domain Antibodies immunology, B7 Antigens immunology, B7 Antigens metabolism, Receptors, Chimeric Antigen immunology, Receptors, Chimeric Antigen metabolism, Herpesvirus 4, Human immunology, Immunotherapy, Adoptive methods, Xenograft Model Antitumor Assays, T-Lymphocytes immunology, T-Lymphocytes metabolism
- Abstract
Encouraged by the observations of significant B7-H3 protein overexpression in many human solid tumors compared to healthy tissues, we directed our focus towards targeting B7-H3 using chimeric antigen receptor (CAR) T cells. We utilized a nanobody as the B7-H3-targeting domain in our CAR construct to circumvent the stability issues associated with single-chain variable fragment-based domains. In efforts to expand patient access to CAR T-cell therapy, we engineered our nanobody-based CAR into human Epstein-Barr virus-specific T cells (EBVST), offering a readily available off-the-shelf treatment. B7H3.CAR-armored EBVSTs demonstrated potent in vitro and in vivo activities against multiple B7-H3-positive human tumor cell lines and patient-derived xenograft models. Murine T cells expressing a murine equivalent of our B7H3.CAR exhibited no life-threatening toxicities in immunocompetent mice bearing syngeneic tumors. Further in vitro evaluation revealed that while human T, B, and natural killer cells were unaffected by B7H3.CAR EBVSTs, monocytes were targeted because of upregulation of B7-H3. Such targeting of myeloid cells, which are key mediators of cytokine release syndrome (CRS), contributed to a low incidence of CRS in humanized mice after B7H3.CAR EBVST treatment. Notably, we showed that B7H3.CAR EBVSTs can target B7-H3-expressing myeloid-derived suppressor cells (MDSC), thereby mitigating MDSC-driven immune suppression. In summary, our data demonstrate that our nanobody-based B7H3.CAR EBVSTs are effective as an off-the-shelf therapy for B7-H3-positive solid tumors. These cells also offer an avenue to modulate the immunosuppressive tumor microenvironment, highlighting their promising clinical potential in targeting solid tumors., Significance: Clinical application of EBVSTs armored with B7-H3-targeting CARs offer an attractive solution to translate off-the-shelf CAR T cells as therapy for solid tumors., (© 2024 The Authors; Published by the American Association for Cancer Research.)
- Published
- 2024
- Full Text
- View/download PDF
39. Phylogenomic and comparative genomic analyses support a single evolutionary origin of flatfish asymmetry.
- Author
-
Duarte-Ribeiro E, Rosas-Puchuri U, Friedman M, Woodruff GC, Hughes LC, Carpenter KE, White WT, Pogonoski JJ, Westneat M, Diaz de Astarloa JM, Williams JT, Santos MD, Domínguez-Domínguez O, Ortí G, Arcila D, and Betancur-R R
- Subjects
- Animals, Evolution, Molecular, Genome genetics, Biological Evolution, Phylogeny, Genomics methods
- Published
- 2024
- Full Text
- View/download PDF
40. Digital cognitive stimulation in elderly breast cancer patients: the Cog-Tab-Age feasibility study.
- Author
-
Binarelli G, Lange M, Santos MD, Duivon M, Capel A, Fernette M, Boué A, Grellard JM, Tron L, Ahmed-Lecheheb D, Clarisse B, Rigal O, Le Fel J, and Joly F
- Subjects
- Humans, Female, Aged, Aged, 80 and over, Patient Satisfaction, Cognitive Behavioral Therapy methods, Mobile Applications, Quality of Life, Breast Neoplasms therapy, Feasibility Studies
- Abstract
Background: Elderly cancer patients often experience cognitive difficulties that can affect their quality of life and autonomy. However, they are rarely included in clinical trials, and only one study has explored the feasibility of cognitive training in this population. While digital cognitive training has been successful in improving cognition in younger patients, its feasibility in elderly patients requires evaluation., Objectives: This feasibility study primarily focused on evaluating patients' ability to use digital cognitive stimulation (usability). Secondary objectives were to evaluate acceptability, adherence, and satisfaction with regard to digital cognitive stimulation in elderly breast cancer patients., Methods: Elderly breast cancer patients at least 70 years old who were receiving cancer treatment (chemotherapy, targeted therapy, and/or radiotherapy) were recruited. Cognitive complaints were evaluated at baseline using the Functional Assessment of Cancer Therapy-Cognitive Function scale (FACT-Cog). Participants were invited to attend three 20-minute sessions of digital cognitive stimulation using HappyNeuron PRESCO software App on tablets, with the first session being supervised by a neuropsychologist and the two others being performed independently either at home or at the cancer center. We hypothesized that participants would spend 10 of the 20 min of the given time with the tablet completing exercises (training time). Thus, the usability of digital cognitive stimulation was defined as completing at least three exercises during the training time (10 min) of one of the two training sessions in autonomy. The proportion of patients who agreed to participate (acceptability) and completion of planned sessions (adherence) were also estimated. Satisfaction was evaluated post-intervention through a self-report questionnaire., Results: 240 patients were initially screened, 60% (n = 145) were eligible and 38% agreed to participate in the study. Included patients (n = 55) had a mean age of 73 ± 3 years, 96% an ECOG score of 0-1 and were undergoing radiotherapy (64%), and/or chemotherapy (47%) and/or targeted therapy (36%) for stage I-II breast cancer (79%). Most patients reported significant cognitive complaints (82%) and 55% had previous experience with digital tools (n = 30). The usability rate was 92%, with 46 out of 50 evaluable participants completing at least three exercises during the training time. The adherence rate was 88%, with 43/50 participants completing all planned sessions. Participants were largely satisfied with the cognitive intervention format (87%). They preferred to complete sessions at the cancer center under the supervision of the neuropsychologist than alone at home (90%)., Conclusions: The high level of usability, adherence and satisfaction in this study shows for the first time the feasibility of digital cognitive stimulation in cancer patients older than 70 years. However, the intervention should be proposed only to patients reporting cognitive complaints and should be structured and supervised to improve acceptability and adherence., Trial Registration: ClinicalTrials identifier: NCT04261153, registered on 07/02/2020., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
41. Wear Rate, Tribo-Corrosion, and Plastic Deformation Values of Co-Cr-Mo Alloy in Ringer Lactate Solution.
- Author
-
Silva RNA, Neto R, Vieira A, Leite P, Radi P, da Silveira CH, Santos MD, Viana F, and Vieira L
- Abstract
This study investigates the tribocorrosion performance of a cast Co-Cr-Mo alloy prepared using casting and electromagnetic stirring (EMS) at specific frequencies. The tribocorrosion behaviour of the alloy was evaluated when exposed to Ringer's lactate solution to optimize the EMS parameters and improve its properties. The research focuses on biomedical implant applications and explores how EMS affects alloy wear and corrosion resistance. As did the friction coefficient and wear volume, the wear rate of samples produced with EMS frequencies of 75 Hz and 150 Hz decreased. These improvements are attributed to the ability of EMS to refine grain size and homogenize the microstructure, thereby increasing the resistance to tribocorrosion. Techniques such as scanning electron microscopy (SEM) and profilometry were used for surface and wear analysis, while mechanical properties were evaluated through instrumented indentation tests. The findings confirm that EMS improves the alloy's durability and tribocorrosion resistance, making it highly suitable for demanding biomedical applications such as joint replacements. This highlights the importance of advanced manufacturing techniques in optimizing biomedical alloys for simulated body conditions., Competing Interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
- Published
- 2024
- Full Text
- View/download PDF
42. Effects of curcumin supplementation on abdominal surgical wound healing.
- Author
-
Santos MD, Campos ECR, Gonçalves Junior R, Koga AY, Kono PA, Salina MVJ, Dalazoana Filho E, Toledo Junior AO, and Lipinski LC
- Subjects
- Rats, Animals, Rats, Wistar, Wound Healing, Water pharmacology, Dietary Supplements, Curcumin pharmacology, Surgical Wound drug therapy
- Abstract
Purpose: To evaluate the effects of curcumin supplementation on abdominal surgical wound healing in rats using clinical, histological, and hematological parameters., Methods: Forty Wistar rats were randomly divided into two groups: the curcumin group, and the control group. The curcumin group received, in addition to water and standard feed, curcumin via gavage at the dose of 200 mg/kg for seven days preceding and seven days following surgery. The control group received only water and standard feed. Both groups underwent median laparotomy and left colotomy. On the eighth postoperative day, the groups were euthanized, and the left colon was resected for histological analysis., Results: In the preoperative evaluation, there was a significant decrease in the mean C-reactive protein levels in the curcumin group (0.06) compared to the control group (0.112) (p = 0.0001). In the postoperative wound healing assessment, a significant decrease was observed in inflammatory infiltrate (p = 0.0006) and blood vessel count (p = 0.0002) in the curcumin group compared to the control group., Conclusions: Curcumin supplementation was able to significantly reduce inflammatory parameters in both pre-and post-operative phases of abdominal surgical wounds in rats.
- Published
- 2024
- Full Text
- View/download PDF
43. Patient-Reported Outcomes (PROs) and PRO Remission Rates in 12,262 Biologic-Naïve Patients With Psoriatic Arthritis Treated With Tumor Necrosis Factor Inhibitors in Routine Care.
- Author
-
Ørnbjerg LM, Rugbjerg K, Georgiadis S, Rasmussen SH, Jacobsson L, Loft AG, Iannone F, Fagerli KM, Vencovsky J, Santos MJ, Möller B, Pombo-Suarez M, Rotar Z, Gudbjornsson B, Cefle A, Eklund K, Codreanu C, Jones G, van der Sande M, Wallman JK, Sebastiani M, Michelsen B, Závada J, Nissen MJ, Sanchez-Piedra C, Tomšič M, Love TJ, Relas H, Mogosan C, Hetland ML, and Østergaard M
- Subjects
- Male, Humans, Female, Tumor Necrosis Factor Inhibitors therapeutic use, Treatment Outcome, Patient Reported Outcome Measures, Pain drug therapy, Arthritis, Psoriatic drug therapy, Arthritis, Psoriatic diagnosis, Antirheumatic Agents therapeutic use, Biological Products therapeutic use
- Abstract
Objective: To evaluate patient-reported outcomes (PROs) after initiation of tumor necrosis factor inhibitor (TNFi) treatment in European real-world patients with psoriatic arthritis (PsA). Further, to investigate PRO remission rates across treatment courses, registries, disease duration, sex, and age at disease onset., Methods: Visual analog scale or numerical rating scale scores for pain, fatigue, patient global assessment (PtGA), and the Health Assessment Questionnaire-Disability Index (HAQ-DI) from 12,262 patients with PsA initiating a TNFi in 13 registries were pooled. PRO remission rates (pain ≤ 1, fatigue ≤ 2, PtGA ≤ 2, and HAQ-DI ≤ 0.5) were calculated for patients still on the treatment., Results: For the first TNFi, median pain score was reduced by approximately 50%, from 6 to 3, 3, and 2; as were fatigue scores, from 6 to 4, 4, and 3; PtGA scores, from 6 to 3, 3, and 2; and HAQ-DI scores, from 0.9 to 0.5, 0.5, and 0.4 at baseline, 6, 12, and 24 months, respectively. Six-month Lund Efficacy Index (LUNDEX)-adjusted remission rates for pain, fatigue, PtGA, and HAQ-DI scores were 24%, 31%, 36%, and 43% (first TNFi); 14%, 19%, 23%, and 29% (second TNFi); and 9%, 14%, 17%, and 20% (third TNFi), respectively. For biologic-naïve patients with disease duration < 5 years, 6-month LUNDEX-adjusted remission rates for pain, fatigue, PtGA, and HAQ-DI scores were 22%, 28%, 33%, and 42%, respectively. Corresponding rates for patients with disease duration > 10 years were 27%, 32%, 41%, and 43%, respectively. Remission rates were 33%, 40%, 45%, and 56% for men and 17%, 23%, 24%, and 32% for women, respectively. For patients aged < 45 years at diagnosis, 6-month LUNDEX-adjusted remission rate for pain was 29% vs 18% for patients ≥ 45 years., Conclusion: In 12,262 biologic-naïve patients with PsA, 6 months of treatment with a TNFi reduced pain by approximately 50%. Marked differences in PRO remission rates across treatment courses, registries, disease duration, sex, and age at onset of disease were observed, emphasizing the potential influence of factors other than disease activity on PROs., (Copyright © 2024 by the Journal of Rheumatology.)
- Published
- 2024
- Full Text
- View/download PDF
44. Urinary proteomics reveals biological processes related to acute kidney injury in Bothrops atrox envenomings.
- Author
-
Brasileiro-Martins LM, Cavalcante SA, Nascimento TP, Silva-Neto AV, Mariano Santos MD, Camillo-Andrade AC, da Gama Fischer JS, Ferreira CC, Oliveira LB, Sartim MA, Costa AG, Pucca MB, Wen FH, Moura-da-Silva AM, Sachett J, Carvalho PC, de Aquino PF, and Monteiro WM
- Subjects
- Animals, Humans, Bothrops atrox, Proteomics, Snake Bites complications, Acute Kidney Injury etiology, Bothrops, Biological Phenomena
- Abstract
Acute kidney injury (AKI) is a critical systemic complication caused by Bothrops envenoming, a neglected health problem in the Brazilian Amazon. Understanding the underlying mechanisms leading to AKI is crucial for effectively mitigating the burden of this complication. This study aimed to characterize the urinary protein profile of Bothrops atrox snakebite victims who developed AKI. We analyzed three groups of samples collected on admission: healthy subjects (controls, n = 10), snakebite victims who developed AKI (AKI, n = 10), and those who did not evolve to AKI (No-AKI, n = 10). Using liquid-chromatography tandem mass spectrometry, we identified and quantified (label-free) 1190 proteins. A panel of 65 proteins was identified exclusively in the urine of snakebite victims, with 32 exclusives to the AKI condition. Proteins more abundant or exclusive in AKI's urine were associated with acute phase response, endopeptidase inhibition, complement cascade, and inflammation. Notable proteins include serotransferrin, SERPINA-1, alpha-1B-glycoprotein, and NHL repeat-containing protein 3. Furthermore, evaluating previously reported biomarkers candidates for AKI and renal injury, we found retinol-binding protein, beta-2-microglobulin, cystatin-C, and hepcidin to be significant in cases of AKI induced by Bothrops envenoming. This work sheds light on physiological disturbances caused by Bothrops envenoming, highlighting potential biological processes contributing to AKI. Such insights may aid in better understanding and managing this life-threatening complication., Competing Interests: The authors have declared that no competing interests exist., (Copyright: © 2024 Brasileiro-Martins et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.)
- Published
- 2024
- Full Text
- View/download PDF
45. New species of redbait from the Philippines (Teleostei, Emmelichthyidae, Emmelichthys ).
- Author
-
Girard MG, Santos MD, and Bemis KE
- Abstract
We describe a new species of redbait in the genus Emmelichthys collected from fish markets on Panay and Cebu islands in the Visayas region of the Philippines. The species is externally similar to E.struhsakeri but is diagnosable by two prominent fleshy papillae associated with the cleithrum and fewer pectoral-fin rays (18-19 vs. 19-21) and gill rakers (30-33 vs. 34-41). Additionally, mitochondrial DNA differentiates this taxon from other species of Emmelichthys . We generate mitochondrial genomes for two of the three type specimens and several other emmelichthyids to place the new taxon in a phylogenetic context. Analysis of the protein-coding mitochondrial loci calls into question the monophyly of two emmelichthyid genera ( Emmelichthys and Erythrocles ) and highlights the need for subsequent analyses targeting the intrarelationships of the Emmelichthyidae., Competing Interests: The authors have declared that no competing interests exist.
- Published
- 2024
- Full Text
- View/download PDF
46. Advancing Efficiency Sustainability in Poultry Farms through Data Envelopment Analysis in a Brazilian Production System.
- Author
-
Marmelstein S, Costa IPA, Terra AV, Silva RFD, Capela GPO, Moreira MÂL, Junior CSR, Gomes CFS, and Santos MD
- Abstract
The production efficiency factor is widely used to measure the zootechnical performance of a batch of broilers. The unit cost of production brings new elements to improve efficiency evaluation and financial sustainability for this activity in agriculture. This research aims to evaluate the production efficiency level of the crop to maximize the return on investment. This study uses Data Envelopment Analysis (DEA) with the computational processing of the SIAD software (Integrated Decision Support System). The variables selected were poultry housing, age at slaughter, feed consumed, mortality, and unit cost. The chosen output variable was the total available weight. The analysis spans 31 decision-making units (DMUs) composed of integrated producers, unveiling a frontier of efficiency delineated by the most exemplary DMUs. Notably, only two DMUs, specifically DMU 4 and DMU 23, approached the threshold of maximum relative efficiency. This research illuminates the critical role of unit cost in enhancing the assessment of production efficiency and financial sustainability within the agriculture environment. By setting benchmarks for efficient management and operational protocols, our findings serve as a cornerstone for improving practices among less efficient DMUs, contributing significantly to the literature on agricultural efficiency and offering actionable insights for the poultry farming sector., Competing Interests: The authors declare no conflicts of interest.
- Published
- 2024
- Full Text
- View/download PDF
47. Molecular Methods for Diagnosis of Monkeypox: A Mini-review.
- Author
-
de Oliveira Thomasi RM, da Silva Correa T, Silva do Carmo D, Rodrigues DF, da Silva Correa LV, Xavier SR, Silva LS, da Silva JO, Santos MD, da Silva Dantas A, da Paz MC, Chávez-Fumagalli MA, Giunchetti RC, Ferraz Coelho EA, Machado JM, and Galdino AS
- Subjects
- Humans, Monkeypox virus genetics, Real-Time Polymerase Chain Reaction methods, Enzyme-Linked Immunosorbent Assay methods, SARS-CoV-2 genetics, SARS-CoV-2 isolation & purification, Animals, COVID-19 diagnosis, COVID-19 virology, COVID-19 epidemiology, Mpox (monkeypox) diagnosis, Mpox (monkeypox) epidemiology, Mpox (monkeypox) virology, Molecular Diagnostic Techniques methods
- Abstract
Background: Monkeypox is a global public health issue caused by the monkeypox virus (MPXV). As of October 28, 2022, a total of 77,115 laboratoryconfirmed cases and 3,610 probable cases, including 36 deaths, were reported, with 9,070 cases reported in Brazil, the second most affected country. The need to develop national technologies for the rapid diagnosis of emerging diseases for mass testing of the population is evident, as observed in the SARS-CoV-2 pandemic., Objective: With that in mind, this article provides an overview of current methods, techniques, and their applications in the molecular detection of monkeypox, focusing the search on real-time polymerase chain reaction (qPCR), polymerase chain reaction (PCR), and polymerase chain reaction-enzyme linked immunosorbent assay (PCRELISA)., Methods: The relevant documents or papers covered in this study were selected by a search in international bibliographic databases. The search terms used in the databases were aimed at summarizing existing knowledge on molecular diagnostic methods, such as monkeypox; MPX, MPXV, qPCR, PCR, PCR-ELISA, diagnosis and detection searched separately or together using the Boolean operator "AND" either in the title or abstract. The searches took place in September 2022, and the corresponding articles were selected between 2012 and 2022., Results: We found 256 documents in total and twelve studies addressing the molecular diagnosis of monkeypox were classified as possible sources for this review., Conclusion: It is evident there is a pressing need to develop national technologies for rapid diagnosis of emerging diseases for mass testing of the population. It is also extremely important to have national detection kits with greater diagnostic capacity to assist in developing effective public policies in countries affected by this disease., (Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.)
- Published
- 2024
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.